Ledger.Open graph →
SEC Form D · filed February 14, 2024

SEELOS THERAPEUTICS, INC

Offering
$3.6M
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Richard W. Pascoe · New York, NYDirectorRaj Mehra · New York, NYExec · DirectorMichael W. Golembiewski · New York, NYExecBrian Lian · New York, NYDirectorMargaret W. Dalesandro · New York, NYDirectorDaniel J. O'Connor · New York, NYDirectorKent Gordon · Salt Lake City, UTDirectorRichard Smith · Orem, UTDirectorMohammed Salama · Orem, UTDirectorMargaret W. Dalesandro · New York, NYDirectorMichael W. Golembiewski · New York, NYExecWilliam Dorsey · Parsippany, NJExec · DirectorRichard M. Craib · San Francisco, CADirectorParas Malde · Camana Bay, Grand Cayman, Cayman IslandsDirectorRiyas Nooruddin · Camana Bay, Grand Cayman, Cayman IslandsDirectorMark Levine · Washington D.C., Washington, D.C.Exec · DirectorSylvester O'Byrne · Dublin, IrelandDirectorMargot Lyons · Dublin, IrelandExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗